Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

Beetaloo Energy: Just add gas – millions in potential data centre revenues
03:06

Barkly Rare Earths: Will this Aussie rare earths play end up at biblical scale?
02:33

Aureka Ltd: Victoria’s newest gold miner!
02:31